1 Adverum Biotechnologies Inc Receivables Turnover Ratio (ADVM), from the third quarter 2025 to the third quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Adverum Biotechnologies Inc   (NASDAQ: ADVM)
 

Adverum Biotechnologies Inc Accounts Receivables Turnover Ratio from the third quarter 2025 to the third quarter 2024

Quarterly Results, Trends, Rankings, Statistics


According to Adverum Biotechnologies Inc Balance Sheet, in the third quarter 2025, company has not reported any Accounts receivable.
See Adverum Biotechnologies Inc Balance Sheet

If we take a look into Healthcare sector Adverum Biotechnologies Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Adverum Biotechnologies Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADVM Receivables Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change - - - - -
Receivable Turnover Ratio (TTM) - - - - -
ADVM's Total Ranking # # # # #
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





ADVM Company Profile • Back to ADVM Efficiency Comparisons • Compare ADVM Receivables Turnover Ratio to its Competitors

Financial Statements
Adverum Biotechnologies Inc 's Accounts Receivable $ 0 Millions Visit ADVM's Balance sheet
Adverum Biotechnologies Inc 's Sales TTM $ 0 Millions Visit ADVM's Income Statement
Sources of ADVM's Revenues Visit ADVM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ADVM's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ADVM's Growth Rates ADVM's Roa ADVM's Inventory Turnover Ratio ADVM's Dividend Comparisons
ADVM's Profitability Ratios ADVM's Roi ADVM's Asset Turnover Ratio ADVM's Dividend Growth
ADVM's Valuation Ratios ADVM's Roe ADVM's Financial Strength Ratios ADVM's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Receivable at quarter ending Sep 30 2025

Date modified: 2026-08-29T17:23:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.